CryoLife, Atlanta, said it reached an agreement with the Food and Drug Administration to immediately resume processing and distributing its non-valved cardiac and vascular tissues on a limited basis. Under the agreement, CryoLife can distribute some tissues for transplant when alternative treatments have been exhausted or are unavailable. CryoLife officials said surgeons already implant its tissues under those circumstances most of the time. The FDA ordered the company to stop distributing human cadaver tissue last month because of its alleged failure to follow procedures to prevent fungal and bacterial contamination. The order affected all soft tissue processed since Oct. 3, one month before a Minnesota man died after a knee operation because of infected tissue. -- by Cinda Becker
FDA allows tissue bank to resume some distribution
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.